Ensysce Biosciences Inc (ENSC)

1.25 -0.13  -9.42% NASDAQ Dec 3, 16:00 1.28 +0.03  +2.40% Pre-Market: 20:00 USD
View Full Chart
Price Chart
View All ENSC News

News

View All Events

Events

Date Type Description
02/28/2022 Earnings Results Q4 2021 Earnings Results
11/15/2021 Earnings Results Q3 2021 Earnings Results
08/16/2021 Earnings Results Q2 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce's products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing the human and economic cost.
  • URL: https://www.ensysce.com
  • Investor Relations URL: https://ir.ensysce.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Feb. 28, 2022
  • Last Earnings Release: Nov. 15, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.